Decision: Favourable
Study Title:
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
NREC Code:
23-NREC-CT-012
Decision:
Favourable
Meeting Date:
05/04/2023
Study Type:
CT application
Principal Investigator:
Dr Janusz Krawczyk
PI Institution:
Galway University Hospital
Sponsor:
European Myeloma Network (EMN)